3191 results for «554»

Filter By

3191 results

Antithrombotic drugs for acute coronary syndromes in women

21 May 2025 – From EuroPCR 2025

Enhance your understanding of antithrombotic drug management in women with acute coronary syndromes (ACS). This session addresses risk stratification balancing ischemic and bleeding risks, evidence-based tailored antithrombotic and revascularisation strategies in high bleeding risk patients, and diagnostic and treatment approaches for MINOCA, with illustrative cases highlighting...

Antithrombotic drugs for acute coronary syndromes in women

Complication management during mitral TEER procedures

21 May 2025 – From EuroPCR 2025

Explore complex case scenarios of complication management during mitral TEER procedures. This session covers haemodynamic challenges, thrombotic events, device malfunctions, and rare embolisation incidents, providing practical insights into effective bailout techniques and procedural problem-solving.

Complication management during mitral TEER procedures

TAVI for aortic regurgitation: on-label and off-label use

21 May 2025 – From EuroPCR 2025

This session reviews on-label and off-label applications of transcatheter aortic valve implantation (TAVI) for treating aortic regurgitation. Examine complex cases including TAVI in patients with aortic dissection, cardiogenic shock, and valve-in-valve interventions, highlighting innovative procedural approaches and bailout strategies.

TAVI for aortic regurgitation: on-label and off-label use

Unconventional situations and complications during cardiovascular interventions

21 May 2025 – From EuroPCR 2025

Explore this session to gain expert tips and practical strategies for managing unexpected complications during cardiovascular interventions. Learn how to anticipate and avoid complications in conventional procedures and discover different approaches to tackle challenging situations in the cathlab through detailed case discussions involving PCI, TAVI, and...

Unconventional situations and complications during cardiovascular interventions

Cathlab harmony: building high-performance teams

21 May 2025 – From EuroPCR 2025

Discover strategies to build and maintain high-performance teams in the cathlab environment. This session outlines how to foster a collaborative culture, address toxic behaviors, and effectively train and integrate team members to enhance teamwork and procedural success in cardiovascular interventions.

Cathlab harmony: building high-performance teams

DES and bioadaptator technologies in contemporary practice

21 May 2025 – From EuroPCR 2025

Delve into contemporary practice with this session on drug-eluting stents (DES) and bioadaptator technologies. Gain insights from international studies on complex PCI outcomes, comparative data from randomized trials, and real-world experiences focusing on high bleeding risk patients and elderly cohorts treated with ultrathin strut and new-generation...

DES and bioadaptator technologies in contemporary practice

Management of high-risk left main lesion

21 May 2025 – From EuroPCR 2025

Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.

Management of high-risk left main lesion

Management of non-culprit lesions in patients with ACS and multivessel disease

21 May 2025 – From EuroPCR 2025

This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case...

Management of non-culprit lesions in patients with ACS and multivessel disease

Did danger shock change my practice?

21 May 2025 – From EuroPCR 2025

Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.

Did danger shock change my practice?

CTO, modern challenges and solutions

21 May 2025 – From EuroPCR 2025

Address modern challenges in chronic total occlusion (CTO) interventions with this session focusing on the latest technologies and techniques. Learn key procedural strategies and best practices through detailed case studies, and understand how evolving technology is shaping the future of CTO revascularization.

CTO, modern challenges and solutions

Strategies in treating double CTO scenarios

21 May 2025 – From EuroPCR 2025

Navigate complex double chronic total occlusion (CTO) scenarios with this session that emphasizes thorough lesion qualification and innovative techniques. Learn strategies including management of ambiguous proximal caps, sequential vessel revascularization, and advanced tools like snaring and deflection to optimize procedural success.

Strategies in treating double CTO scenarios

New evidence in the PFO closure

21 May 2025 – From EuroPCR 2025

Gain new insights into patent foramen ovale (PFO) closure with this session exploring age-related outcomes, risk of atrial arrhythmia, and patient selection improvements. Review various imaging approaches for assessing residual shunts and compare guidance techniques including TEE, fluoroscopy, and intracardiac echo from recent clinical registries.

New evidence in the PFO closure

TAVI for aortic regurgitation: off-label use

21 May 2025 – From EuroPCR 2025

Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...

TAVI for aortic regurgitation: off-label use

More on long-term responsiveness and effectiveness of renal denervation

21 May 2025 – From EuroPCR 2025

This session presents comprehensive data on the long-term responsiveness and effectiveness of renal denervation. Topics include outcomes in patients with chronic kidney disease, arterial stiffness correlations, safety profiles over nine years, and economic evaluations across European healthcare systems.

More on long-term responsiveness and effectiveness of renal denervation

LAA closure and anthrombotic therapies

21 May 2025 – From EuroPCR 2025

Explore contemporary evidence on left atrial appendage (LAA) closure and associated antithrombotic therapies. This session covers strategies for antithrombotic de-escalation, efficacy and safety in patients with anticoagulation contraindications, breakthrough stroke etiology, and anatomical considerations in high-risk atrial fibrillation patients undergoing ablation.

LAA closure and anthrombotic therapies

Large thrombus burden: contemporary solutions

21 May 2025 – From EuroPCR 2025

This session presents contemporary strategies for managing large thrombus burden in STEMI patients. Learn from expert cases demonstrating multiple effective approaches including modified manual thrombus aspiration guided by intravascular ultrasound (IVUS) and streamlined primary PCI techniques, essential for optimizing outcomes in complex thrombotic scenarios.

Large thrombus burden: contemporary solutions

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

22 May 2025 – From EuroPCR 2025

Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.

Clinical and technical factors for decision-making in treatment of left main coronary artery disease

Pharmacotherapy coronary interventions: new insights

22 May 2025 – From EuroPCR 2025

Stay abreast of new insights in pharmacotherapy for coronary interventions with a focus on optimizing patient outcomes. Topics include ticagrelor monotherapy in chronic coronary syndrome post-PCI, analysis of multiple events in high bleeding risk patients from the MASTER DAPT trial, effects of beta-blocker interruption in MI...

Pharmacotherapy coronary interventions: new insights

Optimising TEER in challenging anatomies

22 May 2025 – From EuroPCR 2025

Optimize transcatheter edge-to-edge repair (TEER) strategies in challenging anatomies with focus on tricuspid valve interventions, recognition of multivalvular disease, and planning combined mitral and tricuspid TEER procedures. Case studies highlight feasibility challenges and dual valve repair approaches.

Optimising TEER in challenging anatomies

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure

22 May 2025 – From EuroPCR 2025

Optimize left atrial appendage (LAA) closure outcomes through expert use of cardiac imaging. This session details the role of various imaging modalities in pre-procedural planning, intraprocedural guidance, and post-procedural assessment. Gain practical insights on transesophageal echocardiography, computed tomography, intracardiac echocardiography, and their integration to enhance procedural...

Optimal use of cardiac imaging to plan and guide transcatheter LAA closure
Didn’t find what you were looking for?